May 31, 2017
The FDA has granted marketing clearance to Ra Medical Systems for its DABRA System for peripheral artery disease treatment.
The device is a catheter and excimer laser system for the treatment of complex and diffuse arterial blockages in the lower vessels.
The single-use catheter produces a lumen while minimizing trauma to the vasculature. It is a full catheter tip forward cutter, without the “dead-space” of fiber optic bundle catheters.
The DABRA laser photochemically ablates arterial blockages, reducing calcium, thrombus and atheroma, minimizing downstream debris. The portable laser weighs about 100 pounds. — Cynthia Jessup
To access the article on the FDANEWS’ website click here.